The new platinum-based anticancer agent LA-12 induces retinol binding protein 4 <it>in vivo</it>

The new platinum-based anticancer agent LA-12 induces retinol binding protein 4 <it>in vivo</it>

<p>Abstract</p> <p>Background</p> <p>The initial pharmacokinetic study of a new anticancer agent (<it>OC</it>-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum (IV) (LA-12) was complemented by proteomic screening of rat plasma. The objective of the...

Full description

Bibliographic Details
Main Authors: Bouchal Pavel, Jarkovsky Jiri, Hrazdilova Kristyna, Dvorakova Monika, Struharova Iva, Hernychova Lenka, Damborsky Jiri, Sova Petr, Vojtesek Borivoj
Format: Article
Language:English
Published: BMC 2011-10-01
Series:Proteome Science
Subjects:
(<it>OC</it>-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum (IV) (LA-12)
plasma retinol-binding protein 4
RBP4
cisplatin
adamantylamine
proteomics
Online Access:http://www.proteomesci.com/content/9/1/68

Internet

http://www.proteomesci.com/content/9/1/68

Similar Items